Impacto Públicocivic observatory
Portuguêspt-PTEnglishcurrent languageEspañoles-ES

PUBLIC CONTRACT · 2022

Medicamentos do foro oncológico e imunomodulares

Contract value
€88,262.06
Signed on
20 April 2022
Procedure
Ao abrigo de acordo-quadro (art.º 259.º)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 9222811

PUBLISHED DESCRIPTION

13_2022_104

WHO CONTRACTED

Parties involved

Place of performance
Portugal, Lisboa, Loures
NUTS region
Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee
NOVARTIS FARMA-PRODUT.FARMACEUTICOS, SA · Tax ID 500063524
Bidder
LABORATORIOS PFIZER, LDA · Tax ID 500162166
Bidder
TEVA PHARMA-PRODUTOS FARMACEUTICOS, LDA · Tax ID 507045491
Bidder
Boehringer Ingelheim Portugal, Lda · Tax ID 500293023
Bidder
Merck, SA · Tax ID 500650870

HOW MUCH AND WHEN

Values and timeline

Contract price
€88,262.06
Procedure base price
€319,063.63
Total effective price
Not reported on Portal BASE
Publication date
6 May 2022
Award date
20 April 2022
Signing date
20 April 2022
Performance period
92 days

The contract price is the value agreed in the contract, not the amount paid.

HOW IT WAS CONTRACTED

Procedure and framework

Contract type
Aquisição de bens móveis
Procedure type
Ao abrigo de acordo-quadro (art.º 259.º)
Award criterion
Monofator
CPV code
33600000-6 - Produtos farmacêuticos
Legal basis
Artigo 259.º do Código dos Contratos Públicos
Regime
Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
Framework agreement
CP 2021/6 - Medicamentos do foro oncológico e imunomoduladores
Centralised procedure
No
Environmental criterion
No
Notice
Not stated
Procedure identifier
5864832

KEEP EXPLORING

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts